Trials / Completed
CompletedNCT05485012
Reinforcing Effects of Marijuana and Opioids
Modulation of Drug Intake: Evaluation of Opioid and Cannabinoid Interactions on Drug Self-Administration
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Shanna Babalonis, PhD · Academic / Other
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The primary goals of this study are to examine 1) marijuana modulation of oxycodone self-administration and 2) oxycodone modulation of marijuana self-administration, under controlled conditions and across a range of doses for each drug.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Marijuana | Double-blind administration of marijuana |
| DRUG | Opioid | Double-blind administration of an opioid agonist |
Timeline
- Start date
- 2023-08-03
- Primary completion
- 2025-03-27
- Completion
- 2025-03-27
- First posted
- 2022-08-02
- Last updated
- 2026-04-15
- Results posted
- 2026-04-15
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT05485012. Inclusion in this directory is not an endorsement.